Extension of Time to File SOU

LYZADDIS

SillaJen, Inc.

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88243803
LAW OFFICE ASSIGNED LAW OFFICE 115
MARK SECTION
MARK LYZADDIS (see, http://uspto.report/TM/88243803/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT LYZADDIS
OWNER SECTION (current)
NAME SillaJen, Inc.
INTERNAL ADDRESS Suite 607
MAILING ADDRESS 6th Floor, 111, Hyoyeol-ro, Buk-gu
CITY Busan
ZIP/POSTAL CODE 46508
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Korea, South
EMAIL XXXX
OWNER SECTION (proposed)
NAME SillaJen, Inc.
INTERNAL ADDRESS Suite 607
MAILING ADDRESS 6th Floor, 111, Hyoyeol-ro, Buk-gu
CITY Busan
ZIP/POSTAL CODE 46508
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Korea, South
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Alicia Morris Groos
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE aoipdocket@nortonrosefulbright.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) alicia.groos@nortonrosefulbright.com; andrea.shannon@nortonrosefulbright.com; mary.murchison@nortonrosefulbright.com
CORRESPONDENCE INFORMATION (proposed)
NAME Alicia Morris Groos
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE aoipdocket@nortonrosefulbright.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) alicia.groos@nortonrosefulbright.com; andrea.shannon@nortonrosefulbright.com; mary.murchison@nortonrosefulbright.com
DOCKET/REFERENCE NUMBER KIRN.T0025US
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Oncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 042
CURRENT IDENTIFICATION Providing information in the field of medical and scientific research on cancer and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 2
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 12/17/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 2
SUBTOTAL AMOUNT [EXTENSION FEE] 250
TOTAL AMOUNT 250
SIGNATURE SECTION
SIGNATURE /sangeun ju/
SIGNATORY'S NAME SangEun Ju
SIGNATORY'S POSITION CEO
DATE SIGNED 11/18/2020
FILING INFORMATION
SUBMIT DATE Tue Nov 17 22:18:36 ET 2020
TEAS STAMP USPTO/ESU-XX.XXX.XX.XXX-2
0201117221836674137-88243
803-750f04550fdf4ec2613bd
4311fae95d2456345a7fc45b4
99aef41fc41ef8abba-CC-183
51609-2020111718223740183
6



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: LYZADDIS (see, http://uspto.report/TM/88243803/mark.png)
SERIAL NUMBER: 88243803

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: SillaJen, Inc., having an address of
      Suite 607
      6th Floor, 111, Hyoyeol-ro, Buk-gu
      Busan, 46508
      Korea, South
      Email: XXXX
Proposed: SillaJen, Inc., having an address of
      Suite 607
      6th Floor, 111, Hyoyeol-ro, Buk-gu
      Busan, 46508
      Korea, South
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 12/17/2019.

For International Class 005:
Current identification: Oncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 042:
Current identification: Providing information in the field of medical and scientific research on cancer and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Alicia Morris Groos
      PRIMARY EMAIL FOR CORRESPONDENCE: aoipdocket@nortonrosefulbright.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): alicia.groos@nortonrosefulbright.com; andrea.shannon@nortonrosefulbright.com; mary.murchison@nortonrosefulbright.com

Correspondence Information (proposed):
      Alicia Morris Groos
      PRIMARY EMAIL FOR CORRESPONDENCE: aoipdocket@nortonrosefulbright.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): alicia.groos@nortonrosefulbright.com; andrea.shannon@nortonrosefulbright.com; mary.murchison@nortonrosefulbright.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /sangeun ju/      Date Signed: 11/18/2020
Signatory's Name: SangEun Ju
Signatory's Position: CEO

RAM Sale Number: 88243803
RAM Accounting Date: 11/17/2020

Serial Number: 88243803
Internet Transmission Date: Tue Nov 17 22:18:36 ET 2020
TEAS Stamp: USPTO/ESU-XX.XXX.XX.XXX-2020111722183667
4137-88243803-750f04550fdf4ec2613bd4311f
ae95d2456345a7fc45b499aef41fc41ef8abba-C
C-18351609-20201117182237401836




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed